During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the Lymphoma Hub was pleased to speak to Michele Spina, National Cancer Institute, Aviano, IT. We asked: Why is an elderly prognostic index required for patients with diffuse large B-cell lymphoma, and how can it be used in clinical practice?
Michele Spina discusses the multicenter study behind the development of a novel geriatric assessment tool, the elderly prognostic index. This tool can help address the challenges of managing elderly patients with DLBCL, including the undertreatment, or toxicity associated with unnecessary treatment and polypharmacy. Geriatric assessment can accurately stratify patients based on the prognosis and help to decide on the treatment regimen.